Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 30034-03-8
2. Cefamandole Sodium Salt
3. Sodium Cefamandole
4. Cefamandole (sodium)
5. Cefamandole Sodium [jan]
6. Iy6234odvr
7. Mls000069575
8. Chebi:34614
9. Kefdole
10. Nsc-758169
11. Monosodium (6r,7r)-7-(r)-mandelamido-3-(((1-methyl-1-h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
12. Smr000058843
13. Cefamandole Sodium (jan)
14. Cephamandole Sodium
15. Unii-iy6234odvr
16. Cefamandole Sodium [usp:jan]
17. Prestwick_23
18. Ncgc00017101-01
19. Einecs 250-009-0
20. Kefdole (tn)
21. Cas-30034-03-8
22. Opera_id_59
23. Cephamandole Sodium Salt
24. Sodium;(6r,7r)-7-[[(2r)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
25. Cefamandolesodiumsalt
26. Dsstox_cid_25579
27. Dsstox_rid_80975
28. Dsstox_gsid_45579
29. Chembl1360024
30. Dtxsid2045579
31. Hy-b1128a
32. Hms1570e16
33. Hms2097e16
34. Hms2235i03
35. Cefamandole Sodium [mart.]
36. Cefamandole Sodium [who-dd]
37. Tox21_110777
38. Akos015967200
39. Akos024288585
40. Cs-5991
41. Nsc 758169
42. Sodium (6r-(6alpha,7beta(r*)))-7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
43. C-2463
44. D02191
45. Q27116182
46. Cefamandole Sodium Salt, Antibiotic For Culture Media Use Only
47. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6a,7b(r*)))-, Monosodium Salt
48. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7beta(r*)))-, Monosodium Salt
49. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-mandelamido-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, Monosodium Salt, D-
50. 7beta-(d-mandel-amido)-3-(1-methyl-1h-tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic Acid Sodium Salt
51. 7beta-(d-mandelamido)-3-(1-methyl-1h-tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic Acid Sodium Salt
52. Sodium (6r,7r)-7-{[(2r)-2-hydroxy-2-phenylacetyl]amino}-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
53. Sodium 7beta-[(2r)-2-hydroxy-2-phenylacetamido]-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylate
Molecular Weight | 484.5 g/mol |
---|---|
Molecular Formula | C18H17N6NaO5S2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 7 |
Exact Mass | 484.05995429 g/mol |
Monoisotopic Mass | 484.05995429 g/mol |
Topological Polar Surface Area | 204 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 783 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13619
Submission : 1998-09-01
Status : Inactive
Type : II
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?